ArticleCancer communications (London, England)2020

Favorable response to immunotherapy in a pancreatic neuroendocrine tumor with temozolomide-induced high tumor mutational burden.

Yanshuo Cao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.